Reid Hoffman, Greylock partner, Inflection AI and LinkedIn co-founder, and ‘Superagency' author, joins 'Squawk Box' to discuss China's DeepSeek AI development, impact on the AI technology race, AI investment outlook,

LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies,” have co-founded an

"You can imagine it being a useful tutor across a wide variety of subjects, including even spiritual or counseling or mental ones," the LinkedIn founder said.

What Could Possibly Go Right with Our AI Future," the LinkedIn co-founder makes the case that AI can extend human

Tech investor and LinkedIn co-founder Reid Hoffman is teaming up with cancer researcher Siddhartha Mukherjee on an artificial intelligence drug discovery startup that is launching with $24.6 million of initial funding.

Hoffman isn’t the only prominent Silicon Valley figure betting on A.I.’s promise in medical research. The new technology is expected to generate between $60 billion and $110 billion annually in value for the pharmaceutical and medical-product industries, according to a McKinsey report released last year.

Linkedin co-founder Reid Hoffman joins Morning Joe to discuss the new book 'Superagency: What Could Possibly Go Right with Our AI Future'.

LinkedIn co-founder and AI investor Reid Hoffman argues we shouldn't be afraid of AI or its disruptive capabilities in his new book "Superagency: What Could Possibly Go Right with Our AI Future."

Manas AI Inc., a startup using artificial intelligence to discover new medicines, launched today with $24.6 million in initial funding. The investment was led by General Catalyst and Manas AI co-founder Reid Hoffman. Greylock Partners, where Hoffman was a general partner until 2023, participated as well.

Dedicated to spotlighting global leaders, the Tarnopol series serves as a platform for addressing critical societal issues, including AI’s potential and ethical implications.

Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI leverages proprietary AI, generative computational chemistry, and best in class biology to cut drug development timelines and costs, transforming cancer and rare disease treatments.

LinkedIn co-founder Reid Hoffman and famed oncologist Dr. Siddhartha Mukherjee have raised a whopping $24.6 million in a seed funding round. The money will be used to launch their new artificial intelligence (AI) start-up, Manas AI.